{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:43:32Z","timestamp":1777286612095,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Grants-in-Aid from the Japan Society for the Promotion of Science","award":["16H04912"],"award-info":[{"award-number":["16H04912"]}]},{"name":"Grants-in-Aid from the Japan Society for the Promotion of Science","award":["19H02889"],"award-info":[{"award-number":["19H02889"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Active vitamin D form 1\u03b1,25-dihydroxtvitamin D<jats:sub>3<\/jats:sub> (1,25(OH)<jats:sub>2<\/jats:sub>D<jats:sub>3<\/jats:sub>) plays pivotal roles in calcium homeostasis and osteogenesis via its transcription regulation effect via binding to vitamin D receptor (VDR). Mutated VDR often causes hereditary vitamin D-dependent rickets (VDDR) type II, and patients with VDDR-II are hardly responsive to physiological doses of 1,25(OH)D<jats:sub>3<\/jats:sub>. Current therapeutic approaches, including high doses of oral calcium and supraphysiologic doses of 1,25(OH)<jats:sub>2<\/jats:sub>D<jats:sub>3,<\/jats:sub> have limited success and fail to improve the quality of life of affected patients. Thus, various vitamin D analogues have been developed as therapeutic options. In our previous study, we generated genetically modified rats with mutated Vdr(R270L), an ortholog of human VDR(R274L) isolated from the patients with VDDR-II. The significant reduced affinity toward 1,25(OH)<jats:sub>2<\/jats:sub>D<jats:sub>3<\/jats:sub> of rat Vdr(R270L) enabled us to evaluate biological activities of exogenous VDR ligand without 1\u03b1-hydroxy group such as 25(OH)D<jats:sub>3<\/jats:sub>. In this study, 2\u03b1-[2-(tetrazol-2-yl)ethyl]-1\u03b1,25(OH)<jats:sub>2<\/jats:sub>D<jats:sub>3<\/jats:sub> (AH-1) exerted much higher affinity for Vdr(R270L) in in vitro ligand binding assay than both 25(OH)D<jats:sub>3<\/jats:sub> and 1,25(OH)<jats:sub>2<\/jats:sub>D<jats:sub>3<\/jats:sub>. A robust osteogenic activity of AH-1 was observed in <jats:italic>Vdr<\/jats:italic>(R270L) rats. Only a 40-fold lower dose of AH-1 than that of 25(OH)D<jats:sub>3<\/jats:sub> was effective in ameliorating rickets symptoms in <jats:italic>Vdr<\/jats:italic>(R270L) rats. Therefore, AH-1 may be promising for the therapy of VDDR-II with VDR(R274L).<\/jats:p>","DOI":"10.1038\/s41598-022-16819-7","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T09:03:32Z","timestamp":1658480612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Robust osteogenic efficacy of 2\u03b1-heteroarylalkyl vitamin D analogue AH-1 in VDR (R270L) hereditary vitamin D-dependent rickets model rats"],"prefix":"10.1038","volume":"12","author":[{"given":"Miyu","family":"Nishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naruhiro","family":"Murose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Mano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Isogai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kittaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Ikushiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Sakaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"16819_CR1","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nrd3318","volume":"9","author":"LA Plum","year":"2010","unstructured":"Plum, L. A. & DeLuca, H. F. Vitamin D, disease and therapeutic opportunities. Nat. Rev. Drug Discov. 9, 941\u2013955 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"16819_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2741\/1514","volume":"10","author":"T Sakaki","year":"2005","unstructured":"Sakaki, T., Kagawa, N., Yamamoto, K. & Inouye, K. Metabolism of vitamin D3 by cytochromes P450. Front. Biosci. 10, 119\u2013134 (2005).","journal-title":"Front. Biosci."},{"key":"16819_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00223-012-9619-0","volume":"92","author":"MR Haussler","year":"2013","unstructured":"Haussler, M. R. et al. Molecular mechanisms of vitamin D action. Calcif. Tissue Int. 92, 77\u201398 (2013).","journal-title":"Calcif. Tissue Int."},{"key":"16819_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1507\/endocrj.48.427","volume":"48","author":"S Kitanaka","year":"2001","unstructured":"Kitanaka, S., Takeyama, K., Murayama, A. & Kato, S. The molecular basis of vitamin D-dependent rickets type I. Endocr. J. 48, 427\u2013432 (2001).","journal-title":"Endocr. J."},{"key":"16819_CR5","first-page":"73","volume":"57","author":"S Kato","year":"2002","unstructured":"Kato, S., Yoshizazawa, T., Kitanaka, S., Murayama, A. & Takeyama, K. Molecular genetics of vitamin D-dependent hereditary rickets. Horm. Res. 57, 73\u201378 (2002).","journal-title":"Horm. Res."},{"key":"16819_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/JCI116539","volume":"92","author":"K Kristjansson","year":"1993","unstructured":"Kristjansson, K., Rut, A. R., Hewison, M., O\u2019Riordan, J. L. & Hughes, M. R. Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3. J. Clin. Investig. 92, 12\u201316 (1993).","journal-title":"J. Clin. Investig."},{"key":"16819_CR7","doi-asserted-by":"publisher","first-page":"29148","DOI":"10.1074\/jbc.M100898200","volume":"276","author":"SA Gardezi","year":"2001","unstructured":"Gardezi, S. A. et al. A rationale for treatment of hereditary vitamin D-resistant rickets with analogs of 1 alpha,25-dihydroxyvitamin D3. J. Biol. Chem. 276, 29148\u201329156 (2001).","journal-title":"J. Biol. Chem."},{"key":"16819_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.mce.2011.05.045","volume":"347","author":"PJ Malloy","year":"2011","unstructured":"Malloy, P. J. & Feldman, D. The role of vitamin D receptor mutations in the development of alopecia. Mol. Cell. Endocrinol. 347, 90\u201396 (2011).","journal-title":"Mol. Cell. Endocrinol."},{"key":"16819_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ecl.2010.02.004","volume":"39","author":"PJ Malloy","year":"2010","unstructured":"Malloy, P. J. & Feldman, D. Genetic disorders and defects in vitamin D action. Endocrinol. Metab. Clin. 39, 333\u2013346 (2010).","journal-title":"Endocrinol. Metab. Clin."},{"key":"16819_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1097-2765(00)80413-X","volume":"5","author":"N Rochel","year":"2000","unstructured":"Rochel, N., Wultz, J. M., Mitschler, A., Klaholz, B. & Moras, D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell 5, 173\u2013179 (2000).","journal-title":"Mol. Cell"},{"key":"16819_CR11","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.1038\/s41598-020-62048-1","volume":"10","author":"M Nishikawa","year":"2020","unstructured":"Nishikawa, M. et al. Generation of novel genetically modified rats to reveal the molecular mechanisms of vitamin D actions. Sci. Rep. 10, 5677. https:\/\/doi.org\/10.1038\/s41598-020-62048-1 (2020).","journal-title":"Sci. Rep."},{"key":"16819_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jsbmb.2018.07.012","volume":"185","author":"M Nishikawa","year":"2019","unstructured":"Nishikawa, M. et al. Generation of 1,25-dihydroxyvitamin D3 in Cyp27b1 knockout mice by treatment with 25-hydroxyvitamin D3 rescued their rachitic phenotypes. J. Steroid Biochem. Mol. Biol. 185, 71\u201379 (2019).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"16819_CR13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1096\/fj.03-0140fje","volume":"18","author":"YR Lou","year":"2004","unstructured":"Lou, Y. R. et al. 25-hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells. FASEB J. 18, 332\u2013334 (2004).","journal-title":"FASEB J."},{"key":"16819_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10549-008-9900-0","volume":"113","author":"X Peng","year":"2009","unstructured":"Peng, X., Hawthorne, M., Vaishnav, A., St-Arnaud, R. & Mehta, R. G. 25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture. Breast Cancer Res. Treat. 113, 31\u201341 (2009).","journal-title":"Breast Cancer Res. Treat."},{"key":"16819_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jsbmb.2009.11.011","volume":"118","author":"YR Lou","year":"2010","unstructured":"Lou, Y. R. et al. 25-Hydroxyvitamin D3 is an agonistic vitamin D receptor ligand. J. Steroid Biochem. Mol. Biol. 118, 162\u2013170 (2010).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"16819_CR16","doi-asserted-by":"publisher","first-page":"995","DOI":"10.18632\/oncotarget.6493","volume":"7","author":"AR Verone-Boyle","year":"2016","unstructured":"Verone-Boyle, A. R. et al. Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo. Oncotarget 7, 995\u20131013 (2016).","journal-title":"Oncotarget"},{"key":"16819_CR17","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.mce.2013.11.014","volume":"382","author":"E Munetsuna","year":"2014","unstructured":"Munetsuna, E. et al. Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells. Mol. Cell. Endocrinol. 382, 960\u2013970 (2014).","journal-title":"Mol. Cell. Endocrinol."},{"key":"16819_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/bs.vh.2015.10.010","volume":"100","author":"A Kittaka","year":"2016","unstructured":"Kittaka, A., Takano, M. & Saitoh, H. Vitamin D analogs with nitrogen atom at C2 substitution and effect on bone formation. Vitam. Horm. 100, 379\u2013394 (2016).","journal-title":"Vitam. Horm."},{"key":"16819_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1021\/ml400098w","volume":"4","author":"M Matsuo","year":"2013","unstructured":"Matsuo, M. et al. Synthesis of 2\u03b1-heteroarylalkyl active vitamin d3 with therapeutic effect on enhancing bone mineral density in vivo. ACS Med. Chem. Lett. 4, 671\u2013674 (2013).","journal-title":"ACS Med. Chem. Lett."},{"key":"16819_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jsbmb.2016.11.008","volume":"167","author":"H Mano","year":"2017","unstructured":"Mano, H. et al. Novel screening system for high-affinity ligand of heredity vitamin D-resistant rickets-associated vitamin D receptor mutant R274L using bioluminescent sensor. J. Steroid Biochem. Mol. Biol. 167, 61\u201366 (2017).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"16819_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.bbrc.2018.09.122","volume":"505","author":"H Mano","year":"2018","unstructured":"Mano, H., Takano, M., Ikushiro, S., Kittaka, A. & Sakaki, T. Novel biosensor using split-luciferase for detecting vitamin D receptor ligands based on the interaction between vitamin D receptor and coactivator. Biochem. Biophys. Res. Commun. 505, 460\u2013465 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"16819_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jsbmb.2017.10.024","volume":"178","author":"H Mano","year":"2018","unstructured":"Mano, H., Ikushiro, S., Saito, N., Kittaka, A. & Sakaki, T. Development of a highly sensitive in vitro system to detect and discriminate between vitamin D receptor agonists and antagonists based on split-luciferase technique. J. Steroid Biochem. Mol. Biol. 178, 55\u201359 (2018).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"16819_CR23","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.1046\/j.1432-1327.2000.01680.x","volume":"267","author":"T Sakaki","year":"2000","unstructured":"Sakaki, T. et al. Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24. Eur. J. Biochem. 267, 6158\u20136165 (2000).","journal-title":"Eur. J. Biochem."},{"key":"16819_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jsbmb.2016.11.022","volume":"173","author":"M Takano","year":"2017","unstructured":"Takano, M. et al. Synthesis of the CYP24A1 major metabolite of 2alpha-[2-(tetrazol-2-yl)ethyl]-1alpha,25-dihydroxyvitamin D(3). J. Steroid Biochem. Mol. Biol. 173, 75\u201378 (2017).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"16819_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jsbmb.2018.02.001","volume":"178","author":"K Yasuda","year":"2018","unstructured":"Yasuda, K. et al. Metabolism of 2\u03b1-[2-(tetrazol-2-yl)ethyl]-1\u03b1,25-dihydroxyvitamin D3 by CYP24A1 and biological activity of its 24R-hydroxylated metabolite. J. Steroid Biochem. Mol. Biol. 178, 333\u2013339 (2018).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"16819_CR26","doi-asserted-by":"publisher","first-page":"6745","DOI":"10.1021\/jm400537h","volume":"56","author":"M Nakabayashi","year":"2013","unstructured":"Nakabayashi, M. et al. Crystal structures of hereditary vitamin D-resistant rickets-associated vitamin D receptor mutants R270L and W282R bound to 1,25-dihydroxyvitamin D3 and synthetic ligands. J. Med. Chem. 56, 6745\u20136760 (2013).","journal-title":"J. Med. Chem."},{"key":"16819_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1248\/cpb.51.357","volume":"51","author":"A Kittaka","year":"2003","unstructured":"Kittaka, A., Kurihara, M., Peleg, S., Suhara, Y. & Takayama, H. 2 alpha-(3-hydroxypropyl)- and 2 alpha-(3-hydroxypropoxy)-1 alpha,25-dihydroxyvitamin D3 accessible to vitamin D receptor mutant related to hereditary vitamin D-resistant rickets. Chem. Pharm. Bull. (Tokyo) 51, 357\u2013358 (2003).","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"16819_CR28","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.1021\/jo0491051","volume":"69","author":"N Saito","year":"2004","unstructured":"Saito, N. et al. Design and effcient synthesis of 2alpha-(omega-hydroxyalkoxy)-1alpha,25-dihydroxyvitamin D3 analogues, including 2-epi-ED-71 and their 20-epimers with HL-60 cell differentiation activity. J. Org. Chem. 69, 7463\u20137471 (2004).","journal-title":"J. Org. Chem."},{"key":"16819_CR29","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1016\/j.bmc.2009.05.032","volume":"17","author":"N Saito","year":"2009","unstructured":"Saito, N. et al. Synthesis of 2alpha-propoxy-1alpha,25-dihydroxyvitamin D3 and comparison of its metabolism by human CYP24A1 and rat CYP24A1. Bioorg. Med. Chem. 17, 4296\u20134430 (2009).","journal-title":"Bioorg. Med. Chem."},{"key":"16819_CR30","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1210\/jc.2004-2552","volume":"90","author":"T Matsumoto","year":"2005","unstructured":"Matsumoto, T. et al. A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: A randomized, double-blind, placebo-controlled clinical trial. J. Clin. Endocrinol. Metab. 90, 5031\u20135036 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"16819_CR31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jsbmb.2006.12.088","volume":"103","author":"T Matsumoto","year":"2007","unstructured":"Matsumoto, T. & Kubodera, N. ED-71, a new active vitamin D3, increases bone mineral density regardless of serum 25(OH)D levels in osteoporotic subjects. J. Steroid Biochem. Mol. Biol. 103, 584\u2013586 (2007).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"16819_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0960-0760(95)00219-7","volume":"56","author":"AW Norman","year":"1996","unstructured":"Norman, A. W. et al. Differing shapes of 1 alpha,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: A status report. J. Steroid Biochem. Mol. Biol. 56, 13\u201322 (1996).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"16819_CR33","doi-asserted-by":"publisher","first-page":"re4","DOI":"10.1126\/scisignal.275re4","volume":"2","author":"MT Mizwicki","year":"2009","unstructured":"Mizwicki, M. T. & Norman, A. W. The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Sci. Signal. 2, re4. https:\/\/doi.org\/10.1126\/scisignal.275re4 (2009).","journal-title":"Sci. Signal."},{"key":"16819_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/nu8030135","volume":"8","author":"CS Hii","year":"2016","unstructured":"Hii, C. S. & Ferrante, A. The non-genomic actions of vitamin D. Nutrients 8, 135. https:\/\/doi.org\/10.3390\/nu8030135 (2016).","journal-title":"Nutrients"},{"key":"16819_CR35","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1210\/me.2004-0415","volume":"19","author":"K Skorija","year":"2005","unstructured":"Skorija, K. et al. Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Mol. Endocrinol. 19, 855\u2013862 (2005).","journal-title":"Mol. Endocrinol."},{"key":"16819_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chembiol.2016.12.017","volume":"24","author":"L Asano","year":"2017","unstructured":"Asano, L. et al. Vitamin D metabolite, 25-hydroxyvitamin D, regulates lipid metabolism by inducing degradation of SREBP\/SCAP. Cell Chem. Biol. 24, 207\u2013217 (2017).","journal-title":"Cell Chem. Biol."},{"key":"16819_CR37","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1096\/fj.13-242040","volume":"28","author":"AT Slominski","year":"2014","unstructured":"Slominski, A. T. et al. ROR\u03b1 and ROR \u03b3 are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D. FASEB J. 28, 2775\u20132789 (2014).","journal-title":"FASEB J."},{"key":"16819_CR38","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.ijbiomac.2022.04.048","volume":"209","author":"Y Song","year":"2022","unstructured":"Song, Y. et al. Molecular and structural basis of interactions of vitamin D3 hydroxyderivatives with aryl hydrocarbon receptor (AhR): An integrated experimental and computational study. Int. J. Biol. Macromol. 209, 1111\u20131123 (2022).","journal-title":"Int. J. Biol. Macromol."},{"key":"16819_CR39","doi-asserted-by":"publisher","first-page":"8002","DOI":"10.1038\/s41598-021-87061-w","volume":"11","author":"AT Slominski","year":"2021","unstructured":"Slominski, A. T. et al. Vitamin D and lumisterol derivatives can act on liver X receptors (LXRs). Sci. Rep. 11, 8002 (2021).","journal-title":"Sci. Rep."},{"key":"16819_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/jcc.540040211","volume":"4","author":"BR Brooks","year":"1983","unstructured":"Brooks, B. R. et al. CHARMm: A program for macromolecular energy, minimization, and dynamics calculations. J. Comp. Chem. 4, 187\u2013217 (1983).","journal-title":"J. Comp. Chem."},{"key":"16819_CR41","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/jcc.10306","volume":"24","author":"G Wu","year":"2003","unstructured":"Wu, G., Robertson, D. H., Brooks, C. L. 3rd. & Vieth, M. Detailed analysis of grid-based molecular docking: A case study of CDOCKER\u2014A CHARMm-based MD docking algorithm. J. Comput. Chem. 24, 1549\u20131562 (2003).","journal-title":"J. Comput. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16819-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16819-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16819-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T04:45:34Z","timestamp":1669351534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16819-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["16819"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-16819-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"assertion":[{"value":"11 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12517"}}